NCT03418727 - Dry Eye Disease Study With Brimonidine | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 6, 2017

Primary Completion Date

March 29, 2018

Study Completion Date

March 29, 2018

Conditions

Dry Eye

Interventions

DRUG

Brimonidine

Two products delivered in sequence twice daily.

DRUG

Brimonidine Mono Therapy

Brimonidine given twice daily along with placebo drops

DRUG

sodium carboxymethylcellulose

Placebo given twice daily.

DRUG

Corticosteroid Eye Drop

Eye drop to be administered after Brimonidine in treatment arm 1

Trial Locations (3)

Chicago Cornea Consultants, Hoffman Estates

Brenart Eye Clinic, Yorkville

The Eye Institute of Utah, Salt Lake City